Nicholas A. Butowski, MD, director, Translational Research in Neuro-Oncology, University of California, San Francisco, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging. These findings were reported on at the 2015 Annual Meeting of the Society for Neuro-Oncology.

Imaging a patient during injection has two benefits: a physician can make sure the target is being hit and can also correct any problems that might arise. Prior studies have used convection-enhanced delivery, Butowski says, but have not paired it with real-time imaging.

In this phase I study, researchers sought out to prove safety of the method.

Butowski hopes to take the strategy to the next level, though, by enhancing the delivery and reducing cost.

Videos

Nicholas A. Butowski, MD, discusses an early-stage study of convection-enhanced delivery of nanoliposomal irinotecan with real-time imaging.

Nicholas A. Butowski, MD

Articles

Dr. Butowski on Real-Time Imaging of Nanoliposomal Irinotecan Injection